Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (EDSG)

N Pavlidis; S Aamdal; A Awada; H Calvert; P Fumoleau; R Sorio; C Punt; Jaap Verweij; AT van Oosterom; R Morant; J Wanders; AR Hanauske

Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (EDSG)

N Pavlidis, S Aamdal, A Awada, H Calvert, P Fumoleau, R Sorio, C Punt, Jaap Verweij, AT van Oosterom, R Morant, J Wanders, AR Hanauske

Medical Oncology

Research output: Contribution to journal › Article › Academic › peer-review

30 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	167-171
Number of pages	5
Journal	Cancer Chemotherapy & Pharmacology
Volume	46
Publication status	Published - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Pavlidis, N., Aamdal, S., Awada, A., Calvert, H., Fumoleau, P., Sorio, R., Punt, C., Verweij, J., van Oosterom, AT., Morant, R., Wanders, J., & Hanauske, AR. (2000). Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (EDSG). Cancer Chemotherapy & Pharmacology, 46, 167-171.

@article{78303db93d17474c9a14d1b9935e0d89,

title = "Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (EDSG)",

author = "N Pavlidis and S Aamdal and A Awada and H Calvert and P Fumoleau and R Sorio and C Punt and Jaap Verweij and {van Oosterom}, AT and R Morant and J Wanders and AR Hanauske",

year = "2000",

language = "Undefined/Unknown",

volume = "46",

pages = "167--171",

journal = "Cancer Chemotherapy & Pharmacology",

issn = "0344-5704",

publisher = "Springer-Verlag",

}

Pavlidis, N, Aamdal, S, Awada, A, Calvert, H, Fumoleau, P, Sorio, R, Punt, C, Verweij, J, van Oosterom, AT, Morant, R, Wanders, J & Hanauske, AR 2000, 'Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (EDSG)', Cancer Chemotherapy & Pharmacology, vol. 46, pp. 167-171.

Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (EDSG). / Pavlidis, N; Aamdal, S; Awada, A et al.
In: Cancer Chemotherapy & Pharmacology, Vol. 46, 2000, p. 167-171.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (EDSG)

AU - Pavlidis, N

AU - Aamdal, S

AU - Awada, A

AU - Calvert, H

AU - Fumoleau, P

AU - Sorio, R

AU - Punt, C

AU - Verweij, Jaap

AU - van Oosterom, AT

AU - Morant, R

AU - Wanders, J

AU - Hanauske, AR

PY - 2000

Y1 - 2000

M3 - Article

SN - 0344-5704

VL - 46

SP - 167

EP - 171

JO - Cancer Chemotherapy & Pharmacology

JF - Cancer Chemotherapy & Pharmacology

ER -